IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q2 2019 Holdings

Filed 2019-08-08 | 4 holdings | $14.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$14.0M3,608,17199.7%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$41.4K1,990,0000.3%
Transenterix Inc.COM NEW89366M201$3.2K2,389,3520.0%
Cidara Therapeutics Inc.COM171757107$1.7K1,021,1480.0%